About Trader Power
Our #1 focus is on connecting investors with undervalued small-cap companies that are trading far below their true worth. With an estimated 15,000 publicly traded companies, it’s no surprise that these stocks exist. Of course once these neglected equities begin to get noticed, the climb to their fair valuation can be exceptionally profitable in a very short time.
Investing in small-cap stocks can be very difficult because there are many concepts to understand and the serious trader must learn them all well. Here at TraderPower we give you the edge by presenting you with only the best companies trading at depressed prices. Our featured companies are not only bargains, but they also hold much potential for the future.
You can also learn how to find these gems on your own at our Market Basics section. Here you can learn to analyze companies based on their fundamentals as well as utilize technical analysis to better time your stock purchases and sells. We also have a glossary of various investing terms and a stock screener to help you quickly find your next profitable investment.
Be sure to Sign Up for our weekly newsletter to keep up to date on everything related to the small-cap market and receive alerts on the promising companies we’ve discovered through due diligence, technical analysis and volume studies. You’ll also learn everything you need to know to make intelligent small cap investment choices and grow your portfolio.
Do you know of an undervalued company that needs to get noticed? Let us know at our contact page! If you have a publicly traded company that needs to get noticed, take a look at our many Services and capture the attention of the investor community!
TraderPower Featured Stocks
Top Small Cap Market News
- PostRock (PSTR) Announces $60 Million Investment by White Deer Energy
- Orexigen® Therapeutics (OREX) and Takeda Enter Into Partnership to Commercialize Contrave® in North America
- Sycamore Networks, Inc. (SCMR) Reports Fourth Quarter and Fiscal Year 2010 Financial Results
- Rexahn Pharmaceuticals (RNN) Announces Publication of New Preclinical Research Data for Novel Anticancer Compound RX-8243
- Acasti Pharma Inc. (NEPT) Reports Positive Impacts on Cardiometabolic Associated Disorders
